A few years ago, offering to send someone home to collect a blood sample was a differentiator. Today it is table stakes. The big aggregators — Practo, PharmEasy, 1mg — have spent years training urban India to expect a phlebotomist at the door inside a two-hour window and a report on the phone within a day. In June 2025 even Amazon India rolled out at-home diagnostics through its app. Patients no longer ask whether you do home collection. They assume you do, and they quietly move to someone who does when you cannot.

Home collection stopped being optional

The numbers back up the shift. India's home diagnostic testing market was worth roughly 412 million dollars in 2025 and is projected to keep climbing through the next decade. For a single-centre or small-chain lab, the threat is not that home collection is unprofitable — it is that a patient who wants it and cannot get it from you will book an aggregator, and once that phlebotomist has their address and their history, the next test goes there too. Losing the sample means losing the relationship.

The promise is two hours. The reality is logistics.

Here is the uncomfortable truth: the marketing is 'convenience', but the operation is a courier business with medical constraints. A home-collection order has to be booked, matched to a phlebotomist who is actually free and near enough, routed sensibly so one person can do five collections in a morning, and returned to the lab with the sample intact and correctly identified. Get any of that wrong and you have a redraw, an angry patient, or a result you cannot trust. Run it on phone calls and a WhatsApp group, and the cracks show fast:

  • Bookings taken verbally, with the address or test written down wrong
  • Two phlebotomists sent across town when one route would have covered both
  • Samples that arrive unlabelled or mislabelled, forcing a redraw
  • No visibility on turnaround time, so the patient calls before you can
  • Home-collection charges that never make it onto the final bill
The sample is only as trustworthy as the chain that brought it in.
The sample is only as trustworthy as the chain that brought it in.

The re-keying tax nobody budgets for

The quiet killer in a small lab is re-keying. An order comes in on WhatsApp and gets written on a slip. The slip is re-entered at the front desk. The sample is matched by hand. The result is typed in, and the report is assembled separately. Every one of those hops is a chance to transpose a digit, swap two patients, or lose a test. A workflow that goes from order to result to report without re-entering the same data is not a luxury; it is the single biggest source of both errors and delay. The fix is boringly effective: capture the order once, barcode the sample at the point of collection, and let that barcode carry the identity all the way to the signed report.

Billing that stays GST-clean

Labs sit in a slightly awkward GST position. Most diagnostic tests fall under the healthcare services exemption, so they are not taxed — but a lab also sells things that may not be exempt, such as certain wellness packages, product sales, or convenience charges. If your billing does not know the difference, you either over-charge tax and irritate patients or under-charge and create a liability. Clean, itemised invoices that correctly separate exempt tests from taxable extras are what keep that tidy, and they matter more as your package and home-collection revenue grows.

Order to result to report — the fewer hands re-typing, the fewer mistakes.
Home collection is not a feature you switch on. It is a logistics discipline that either has a system behind it or falls apart on a busy morning.

Reports that are ready to go digital

The last mile is delivery. Patients increasingly want a report they can pull up on their phone and share with a doctor without a physical trip. India's digital health rails under ABDM make that possible — linking a report to a patient's health account so it lives somewhere they control. You do not have to do everything at once, but a lab building its systems today should assume that a shareable, digital-first report is where things are heading, and pick tooling that will not fight that when the time comes.

Where BizRevolt fits

We will name the obvious comparison. CrelioHealth is a strong, feature-rich LIMS — and it is built, and priced, for larger labs and chains. If you run one centre or a small growing network, a lot of that platform is capacity you pay for and do not use. BizRevolt's Diagnostics workspace is built for that single-centre and growing lab: order to result to report with no re-keying, home-collection booking and tracking, referring-doctor records, GST-clean billing, and reports ready for the digital rails — without the premium LIMS price tag.

It starts at 999 rupees a month for a single lab and 2,499 for the Growth tier as you add collection points. If you want to see how your current home-collection process — however held-together it is right now — would map into a single workflow, the fastest way is to walk us through it. Message the founder on WhatsApp, or call +91 91 0657 4865, and we will give you an honest read on whether it fits a lab your size.